发明名称 MODULATION OF NKG2D
摘要 The present invention relates to methods and compositions for treating and/or preventing inflammation associated with viral infection and solid organ transplant rejection. In particular, the present invention provides therapeutics for impairing the expansion and function of autoreactive T cells, NK cells and/or NKT cells, by modulating NKG2D.
申请公布号 US2016311906(A1) 申请公布日期 2016.10.27
申请号 US201615081305 申请日期 2016.03.25
申请人 The Regents of the University of California 发明人 LANIER Lewis L.;OGASAWARA Koetsu;BLUESTONE Jeffrey A.
分类号 C07K16/28;G01N33/50 主分类号 C07K16/28
代理机构 代理人
主权项
地址 Oakland CA US